Paper33192532
Combining 18F-FDG PET/CT and Serum Lactate Dehydrogenase for Prognostic Evaluation of Small Cell Lung Cancer.
Lin X and 4 others. Front Pharmacol, 2020. Cited by 10 papers, by iCite.
Cite this record
ConductScience Library. Combining 18F-FDG PET/CT and Serum Lactate Dehydrogenase for Prognostic Evaluation of Small Cell Lung Cancer. Papers, record 33192532. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33192532
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Combining 18F-FDG PET/CT and Serum Lactate Dehydrogenase for Prognostic Evaluation of Small Cell Lung Cancer.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References23
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27912830 | Advances in Small Cell Lung Cancer. | Hematol Oncol Clin North Am | 2017 | https://conductscience.org/library/papers/27912830 | PubMed |
| 2 | 26844524 | The Highest Metabolic Activity on FDG PET Is Associated With Overall Survival in Limited-Stage Small-Cell Lung Cancer. | Medicine (Baltimore) | 2016 | https://conductscience.org/library/papers/26844524 | PubMed |
| 3 | 3011712 | Prognostic influence of TNM staging and LDH levels in small cell carcinoma of the lung (SCCL). | Int J Radiat Oncol Biol Phys | 1986 | https://conductscience.org/library/papers/3011712 | PubMed |
| 4 | 19460998 | Understanding the Warburg effect: the metabolic requirements of cell proliferation. | Science | 2009 | https://conductscience.org/library/papers/19460998 | PubMed |
| 5 | 19318478 | High tumor metabolic activity as measured by fluorodeoxyglucose positron emission tomography is associated with poor prognosis in limited and extensive stage small-cell lung cancer. | Clin Cancer Res | 2009 | https://conductscience.org/library/papers/19318478 | PubMed |
| 6 | 29970686 | Clinical evaluation of potential usefulness of serum lactate dehydrogenase level in follow-up of small cell lung cancer. | J Cancer Res Ther | 2018 | https://conductscience.org/library/papers/29970686 | PubMed |
| 7 | 21946983 | Prognostic value of metabolic tumor burden on 18F-FDG PET in nonsurgical patients with non-small cell lung cancer. | Eur J Nucl Med Mol Imaging | 2012 | https://conductscience.org/library/papers/21946983 | PubMed |
| 8 | 12483413 | Prognostic value of [18F]FDG-PET imaging in small cell lung cancer. | Eur J Nucl Med Mol Imaging | 2003 | https://conductscience.org/library/papers/12483413 | PubMed |
| 9 | 26320828 | Prognostic Value of Preradiotherapy (18)F-FDG PET/CT Volumetrics in Limited-Stage Small-Cell Lung Cancer. | Clin Lung Cancer | 2016 | https://conductscience.org/library/papers/26320828 | PubMed |
| 10 | 25651787 | Global cancer statistics, 2012. | CA Cancer J Clin | 2015 | https://conductscience.org/library/papers/25651787 | PubMed |
| 11 | 22214967 | Update on small cell carcinoma and its differentiation from squamous cell carcinoma and other non-small cell carcinomas. | Mod Pathol | 2012 | https://conductscience.org/library/papers/22214967 | PubMed |
| 12 | 21996089 | SUVmax during 18FDG-PET scanning in small cell lung cancer: similar information as in non-small cell lung cancer? | Lung Cancer | 2012 | https://conductscience.org/library/papers/21996089 | PubMed |
| 14 | 25310425 | Small cell lung carcinoma: staging, imaging, and treatment considerations. | Radiographics | 2014 | https://conductscience.org/library/papers/25310425 | PubMed |
| 15 | 23999443 | Targeting lactate metabolism for cancer therapeutics. | J Clin Invest | 2013 | https://conductscience.org/library/papers/23999443 | PubMed |
| 16 | 1851821 | The prognostic significance of pretreatment serum lactate dehydrogenase in patients with small-cell lung cancer. | J Clin Oncol | 1991 | https://conductscience.org/library/papers/1851821 | PubMed |
| 17 | 22270509 | Whole-body metabolic tumour volume of 18F-FDG PET/CT improves the prediction of prognosis in small cell lung cancer. | Eur J Nucl Med Mol Imaging | 2012 | https://conductscience.org/library/papers/22270509 | PubMed |
| 18 | 26599271 | Limited Prognostic Value of SUV max Measured by F-18 FDG PET/CT in Newly Diagnosed Small Cell Lung Cancer Patients. | Oncol Res Treat | 2015 | https://conductscience.org/library/papers/26599271 | PubMed |
| 19 | 19652623 | The IASLC Lung Cancer Staging Project: proposals regarding the relevance of TNM in the pathologic staging of small cell lung cancer in the forthcoming (seventh) edition of the TNM classification for lung cancer. | J Thorac Oncol | 2009 | https://conductscience.org/library/papers/19652623 | PubMed |
| 20 | 11086206 | Comparative prognostic value of lactate dehydrogenase and neuron-specific enolase in small-cell lung cancer patients treated with platinum-based chemotherapy. | Lung Cancer | 2000 | https://conductscience.org/library/papers/11086206 | PubMed |
| 21 | 26909082 | Lactate Contribution to the Tumor Microenvironment: Mechanisms, Effects on Immune Cells and Therapeutic Relevance. | Front Immunol | 2016 | https://conductscience.org/library/papers/26909082 | PubMed |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42787882 | Evaluation of the Systemic Immune-Inflammation Index, Neutrophil-to-Lymphocyte Ratio, and Platelet-to-Lymphocyte Ratio in Patients Diagnosed with Lung Cancer by Bronchoscopy in Relation to Disease Stage and PET/CT SUVmax. | World J Nucl Med | 2026 | https://conductscience.org/library/papers/42787882 | PubMed |
| 42724674 | Survival trends in extensive-stage small cell lung cancer in the pre-immunotherapy and immunotherapy eras: a population-based SEER study. | J Thorac Dis | 2026 | https://conductscience.org/library/papers/42724674 | PubMed |
| 42663294 | Research progress on lactate metabolism in lung cancer: Tumorigenesis, drug resistance and clinical translation (Review). | Oncol Rep | 2026 | https://conductscience.org/library/papers/42663294 | PubMed |
| 42474610 | Development of a 18F-FDG PET/CT-based radiomic risk score as an independent prognostic factor in small cell lung cancer. | Ann Nucl Med | 2026 | https://conductscience.org/library/papers/42474610 | PubMed |
| 42307116 | Lysine lactylation-mediated post-translational modification: Molecular mechanisms and therapeutic target exploration in tumour drug resistance. | Clin Transl Med | 2026 | https://conductscience.org/library/papers/42307116 | PubMed |
| 42291355 | The role of tumor metabolic reprogramming in acquired anti-PD-1/PD-L1 resistance. | Transl Lung Cancer Res | 2026 | https://conductscience.org/library/papers/42291355 | PubMed |
| 39585433 | Small cell lung cancer with liver metastases: from underlying mechanisms to treatment strategies. | Cancer Metastasis Rev | 2024 | https://conductscience.org/library/papers/39585433 | PubMed |
| 36882606 | Primary tumor SUVmax and ratio of SUVmax to primary tumor size on pretreatment 18F-FDG-PET/CT scan in small cell lung cancer : Which is superior for the prognosis? | Wien Klin Wochenschr | 2023 | https://conductscience.org/library/papers/36882606 | PubMed |
| 36677035 | Glycolytic Plasticity of Metastatic Lung Cancer Captured by Noninvasive 18F-FDG PET/CT and Serum 1H-NMR Analysis: An Orthotopic Murine Model Study. | Metabolites | 2023 | https://conductscience.org/library/papers/36677035 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| TENM1 | 10178 | PubTator's text mining | https://conductscience.org/library/genes/10178 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33192532
GET https://conductscience.org/api/papers/v1/33192532/references?page=2